Answers are grounded in this paper and cite their sources.
Tau, an intrinsically disordered protein abundant in neuronal axons, forms cooperative condensates on microtubule (MT) surfaces that regulate motor proteins and protect MTs from severing enzymes. Disease-associated mutations at residue 5 in the N-terminal projection domain of tau, far from the MT-tau binding interface, have been linked to progressive supranuclear palsy (PSP) (R5L) and frontotemporal dementia (FTD) (R5H). While R5L was previously shown to disrupt tau condensate formation on MT surfaces, it remained unclear whether R5H shares this phenotype. Using total internal reflection fluorescence (TIRF) microscopy, we show that both mutations reduce condensate packing density compared to WT tau under sub-saturating conditions at physiological pH (7.4), indicating impaired tau-tau cooperativity despite their distal location from the MT-tau binding interface. Single-molecule measurements further show both the dwell time and landing rate of tau within condensates are reduced while behavior on bare MTs remains unchanged, implicating weakened tau-tau cooperativity rather than disrupted binding to MTs. Strikingly, mutational analysis identifies the positive charge at residue 5 as critical for tau condensate formation: the charge-preserving R5K substitution retains WT-like behavior, whereas the charge-eliminating R5I substitution behaves like R5H/R5L. Further supporting this mechanism, R5H exhibits a pronounced pH dependence, transitioning from WT-like behavior at pH 6.4 to R5L-like behavior at pH 7.4 upon histidine deprotonation. Together, these findings establish that the positive charge at R5 is critical for tau condensate formation on MT surfaces and identify a common mechanism linking PSP and FTD.
No takes yet. Share an insight, caveat, or question.
Gangwar et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: